Abstract

In vivo bioprinting, fabricating tissue-engineered implants directly in a patient, was recently developed to overcome the logistical and clinical limitations of traditional bioprinting. In vivo printing reduces the time to treatment, allows for real-time reconstructive adjustments, minimizes transportation challenges, improves adhesion to remnant tissue and ensuing tissue integration, and utilizes the body as a bioreactor. Unfortunately, most in vivo printers are frame-based systems with limited working areas that are incompatible with the human body and lack portability. Robotic arms have recently been used to resolve these challenges, but developed systems suffered from complex deposition or cross-linking modalities and lacked bioink temperature control, drastically limiting the use of biologically favorable bioinks. Here, we created a portable and affordable robotic arm bioprinter with precise control over bioink temperature. The system maintained biomaterial ink temperatures from 6 to 60 ± 0.05 °C. We tested a bioprinting optimization strategy with different temperature-sensitive bioinks. In addition, we engineered a personalized in vivo printing strategy derived from in situ scanning and model reconstruction that utilizes freely available and open-source software. We further demonstrated the benefits of human-derived bioinks made of blood components. The system and the proposed human-derived bioinks pave the way toward the personalization of scaffold-based regenerative medicine.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.